Review of NICE ADHD Treatment Assessment
Author Information
Author(s): Michael Schlander
Primary Institution: Institute for Innovation & Valuation in Health Care (InnoValHC)
Hypothesis
The analysis critiques the NICE appraisal of ADHD treatments and evaluates its effectiveness and economic analysis.
Conclusion
The NICE technology assessment's conclusions are based on insufficient evidence and methodological flaws.
Supporting Evidence
- The NICE assessment could not differentiate between the efficacy of different ADHD medications.
- The economic model was primarily driven by cost differences rather than clinical effectiveness.
- The assessment relied on a small number of short-term studies, leading to potential biases.
Takeaway
The study looks at how a big health organization evaluated ADHD treatments and found many problems with their conclusions.
Methodology
A qualitative study analyzing the NICE Technology Appraisal No. 98 report and related literature.
Potential Biases
Potential bias due to reliance on a limited number of short-term studies and exclusion of relevant data.
Limitations
The assessment did not consider psychosocial interventions and had incomplete literature searches.
Participant Demographics
Focus on children and adolescents with ADHD.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website